Completed PHASE2 INTERVENTIONAL NCT00244725

Odiparcil For The Prevention Of Venous Thromboembolism

A Dose Ranging Trial for the Evaluation of the Safety, Tolerability and Efficacy of Odiparcil in the Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery

Sponsor: GlaxoSmithKline

Conditions Deep Vein Thrombosis Fibrillation, Atrial Pulmonary Embolism Venous Thromboembolism

Interventions Coumadin Odiparcil Warfarin

Updated 7 times since 2017 Last updated: Mar 21, 2017 Started: Sep 30, 2005 Primary completion: Sep 30, 2006 Completion: Sep 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Deep Vein Thrombosis and Fibrillation, Atrial and is currently completed. GlaxoSmithKline leads this study, which shows 7 recorded versions since 2005 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 2 earlier versions

Jun 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Jun 2017 [monthly]

Completed PHASE2

First recorded

Sep 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

GlaxoSmithKline

Data source: GlaxoSmithKline

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ajax, Canada , Allentown, United States , Altoona, United States , Baltimore, United States , Banning, United States , Baton Rouge, United States , Bialystok, Poland , Birmingham, United Kingdom , Birmingham, United States , Boise, United States and 80 more locations